華東醫藥(000963.SZ):注射用地西他濱(祥珂®)擬中標第五批全國藥品集採
格隆匯6月23日丨華東醫藥(000963.SZ)公佈,2021年6月23日,公司全資子公司杭州中美華東製藥有限公司(“中美華東”)參加了國家組織藥品集中採購和使用聯合採購辦公室(“聯採辦”)組織的第五批全國藥品集中採購的投標工作。中美華東的注射用地西他濱(祥珂®)擬中標此次集中採購,且中美華東根據各省市場潛力已完成目標供應省份的遴選。

注:根據此次集採中標規則,本輪採購週期原則上為3年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.